Renato Delascio Lopes

Adjudicating Heart Failure Events in Participants Receiving Hemodialysis: Findings from Evaluation of Cinacalcet Hydrochloride Therapy to Lower Cardiovascular Events (EVOLVE) Trial

Apixaban for stroke prevention in subclinical atrial fibrillation detected by an implantable cardiac monitor: A subgroup analysis of ARTESiA

Comparative Prognosis of Chagas and Other Cardiomyopathies

Potential Mediators of Efpeglenatide's Cardiovascular Benefit: An Exploratory Analysis of the AMPLITUDE-O Trial

Practice Patterns in Antiplatelet Management of Patients With Acute Coronary Syndromes Treated Medically Without Revascularisation: A Multicentre Survey

Recurrent myocardial infarction identified by centralized troponin review: Insights from the MINT trial

Registry of atrial fibrillation in Latin America: Primary results of the LACROSS study

Renato Delascio Lopes is a cardiovascular medicine faculty leader whose work connects Duke-based clinical research with education and research activity in Brazil. He is Professor of Medicine and a member of the Duke Clinical Research Institute. His research interests include atrial fibrillation and antithrombotic therapy in acute coronary syndromes, cardiovascular biomarkers, thrombosis and anticoagulation, heart disease in older adults, and metabolomics. He earned an M.D. from the University of Santo Amaro in 2001, a Ph.D. from the Paulista Medical School, University of São Paulo, in 2006, and an M.H.S. from Duke in 2009. His past appointments include Professor, Associate Professor, and Adjunct Assistant Professor of Medicine. A 2022 profile also identified him as a BCRI founder and director and as a professor at Escola Paulista de Medicina.

When Emulation Falls Short: Reaffirming the Role of Randomized Clinical Trials